Men who take aspirin regularly may have a lower risk of dying from prostate cancer, a new study suggests.
Dr. Christopher Allard, a urologic oncology fellow at Harvard Medical School in Boston reported that the regular intake of aspirin decreases the risk of prostate cancer death by almost 40%. That may suggest men could have one more reason to consider regular aspirin use.
The findings were presented Jan.
Diagnoses of early prostate cancer continue to decline in the United States, following the 2011 U.S. Preventive Services Task Force (USPSTF) recommendation against routine screening for the disease.
For those of you not familiar with this screening, the analysis involves a simple blood test that identifies levels of PSA (prostate specific antigen), a protein produced by the prostate gland. While the test can determine when cancer exists, it can… Read More »
In recognition of September as Prostate Cancer Awareness Month, PCaAWARE is pleased to share the following reminders.
— Prostate cancer is the second most common cancer among men, behind skin cancer, and affects one in seven men.
— Prostate cancer is the second leading cause of cancer death in American men, behind only lung cancer.
— In 2016 approximately 250,000 new cases will be diagnosed in the United States; about… Read More »
Some research suggests that drinking pomegranate juice may slow the progression of prostate cancer.
For example, in a study of men with recurrent prostate cancer and rising prostate-specific antigen (PSA) levels, researchers found that taking pomegranate juice extract significantly slowed the rate at which PSA was rising (PSA doubling time). A longer PSA doubling time can indicate that the cancer may be progressing less rapidly.
But this study did not… Read More »
Prostate cancer screening with prostate-specific antigen (PSA) has been shown to reduce death and the spread of prostate cancer to other parts of the body, but the PSA test remains highly controversial as it frequently leads to over diagnosis and over treatment of men who may not be at risk. Smarter screening strategies that can improve the accuracy of diagnosing lethal prostate cancer are urgently needed. Through a prospective… Read More »
Many studies have shown the negative effect health providers’ underlying prejudices can have on the doctor-patient relationship and the decisions patients make about their care. And according to a new study, oncologists are not immune.
Some cancer physicians are letting their implicit racial biases get in the way of quality treatment for Black patients.
Researchers at the Karmanos Cancer Institute in Detroit, Michigan, studied video-recorded interactions between 18… Read More »
Tagged with: Bayer, black patients, diet and prostate cancer, Harvard Medical School, JAMA Oncology, Journal of Clinical Oncology, Karmanos Cancer Institute, Louis A. Penner, men who speak up, Office of Minority Health, Quoc-Dien Trinh, real men get tested, Reuters, University of Colorado Cancer Center, ZERO
Jeff Jones was aware of the risks associated with high Prostate-Specific Antigen (PSA) levels.
In January 2015 after an annual checkup, doctors told him his PSA levels were high and encouraged further monitoring. He underwent blood work and a biopsy that revealed nothing more than what he already knew.
So when doctors suggested he receive one more biopsy after failed attempts to lower his PSA, Jones was in no rush… Read More »
Men who have prostate cancer could reduce their risk of death by up to a third by eating nuts regularly, new research has suggested.
The researchers, experts at Harvard Medical School in Boston, studied 47,000 men over 26 years and identified 6,800 who had developed prostate cancer.
Writing in the British Journal of Cancer they found no “statistically significant associations” between eating nuts and being diagnosed with prostate cancer.
However,… Read More »
